Comparative analysis of viral load in blood, vaginal and cervical specimens among HIV women using family planning methods

封面


如何引用文章

全文:

详细

Study devoted to HIV viral load assessment (blood versus cervical and vaginal specimen) among HIV infected women using effective hormonal, intrauterine and barrier contraceptive methods in short-term prospective. Based on lab data and contraceptive methods authors formulate assumptions of HIV sexual transmission.

作者简介

Anna Samarina

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, PhD, Head of Department women and children health

Zoya Lisitsina

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, PhD, Head of clinical laboratory

Margarita Martirosyan

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, gynecologist of Department women and children health

Natalya Dementyeva

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, clinical laboratory physician

Lyudmila Krutitskaya

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, PhD, clinical laboratory physician

Aza Rakhmanova

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
MD, Professor, Principial infectious specialist of Saint-Petersburg, deputy director of St.-Petersburg AIDS Center

Nikolay Belyakov

St.-Petersburg AIDS Center

Email: avsamarina@mail.ru
member of RAMS, MD, Professor, Head of St.-Petersburg AIDS Center

参考

  1. Беляков Н. А., Виноградова Т. Половой путь передачи ВИЧ в развитии эпидемии // ВИЧ-инфекция и иммуносупрессии. — 2011. — Т. 3, № 4. — С. 7–20.
  2. Женщина, ребенок и ВИЧ / ред. Н. А. Беляков, Н. Ю. Рахманина, А. Г. Рахманова. — СПб.: Балтийский образовательный центр, 2012. — 600 с.
  3. Самарина А. В., Ястребова Е. Б., Рахманова А. Г. Динамика и анализ причин передачи ВИЧ от матери к ребенку в Санкт-Петербурге // ВИЧ-инфекция и иммуносупрессии. — 2012. — Т. 4, № 3. — С. 9–18.
  4. Факторы, определяющие выбор метода контрацепции у ВИЧ-инфицированных женщин / А. В. Самарина, Н. Ю. Акатова, М. К. Уайтмэн, Д. М. Киссин, К. М. Кэртис, П. А. Марчбэнкс, Д. Дж. Джэмисон, М. М. Мартиросян, Н. Ревзина, С. Д. Хиллис // ВИЧ-инфекция и иммуносупрессии. — 2012. — Т. 4, № 1. — С. 57–68.
  5. Baeten J. M., Lavreys L., Overbaugh J. The influence of hormonal contraceptive use on HIV-1 transmission and disease progression // Clin. Infect. Dis. — 2007. — Vol. 45, N 3. — P.360–369.
  6. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1 / F. A. Plummer, J. N. Simonsen, D. W. Cameron [et al.] // J. Infectious Diseases. — 1991. — Vol.163, N 2. — P. 233–239.
  7. Contraception to prevent HIV-positive births: current contribution and potential cost savings in PEPFAR countries / H. W. Reynolds, B. Janowitz, R. Wilcher [et al.] // Sexually Transmitted Infections. — 2008. — Vol. 84, N 2. — P. 49–53.
  8. De Vincenzi I. A longitudinal study of human immunodeficiency virus transmission by heterosexual partners // New England J. Medicine. — 1994. — Vol. 331, N 6. — P. 341–346.
  9. Determination of contraceptive choice among women with HIV / M. Whiteman, D. Kissin, A. V. Samarina [et al.] // AIDS. — 2009. — Vol. 23, N 1. — P. 47–54.
  10. Hel Z., Stringer E., Mestecky J. Sex steroid hormones, hormonal contraception, and the immunobiology of human immunodeficiency virus-1 infection // Endocr. Rev. — 2010. — Vol. 31, N 1. — P. 79–97.
  11. Hormonal Contraception and HIV: Science and Policy. Africa Regional Meeting; Nairobi. 19–21 September 2005. URL: http: // whqlibdoc.who.int/hq/2006/WHO_RHR_06.4_eng.pdf. (дата обращения 01.06.2013).
  12. Hormonal contraception and the risk of HIV acquisition / C. S. Morrison, B. A. Richardson, F. Miro [et al.] // AIDS. — 2007. — Vol. 21, N 1. — P. 85–95.
  13. Hormonal contraception and the risk of HIV acquisition among women in South Africa / C. S. Morrison, S. Skoler-Karpoff [et al.] // AIDS. — 2012. — Vol. 26, N 4. — P. 497–504.
  14. Hormonal contraceptive use and HIV disease progression among women in Uganda and Zimbabwe / C. S. Morrison, P. L. Chen, I. Nankya [et al.] // J. Acquir. Immune. Defic. Syndr. — 2011. — Vol. 57, N 2. — P. 157–164.
  15. Hormonal contraceptive use and HIV-1 infection in a population-based cohort in Rakai, Uganda / M. Kiddugavu, F. Makumbi, M. J. Wawer [et al.] // AIDS. — 2003. — Vol.17, N 2. — P. 233–240.
  16. Hormonal contraceptive use and risk of HIV-1 disease progression / R. Heffron, N. Mugo, K. Ngure [et al.] // AIDS. — 2013. — Vol. 14, N 27, pt. 2. — P. 61–67.
  17. Hormonal contraceptive use and risk of HIV-1 transmission: a prospective cohort analysis / R. Heffron, D. Donnell, H. Rees, C. Connie [et al.] // Lancet Infect. Dis. — 2012. — Vol. 12, N 1. — P. 19–26.
  18. Hormonal contraceptive use, herpes simplex virus infection, and risk of HIV-1 acquisition among Kenyan women / J. M. Baeten, S. Benki, V. Chohan [et al.] // AIDS. — 2007. — Vol. 21, N 13. — P. 1771–1777.
  19. Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort / I. Kleinschmidt, H. Rees, S. Delany [et al.] // Contraception. — 2007. — Vol. 75, N 6. — P. 461–467.
  20. Population Division, United Nations Department of Economic Social Affairs. World Contraceptive Use 2009. URL: http://www.un.org/esa/population/publications/contraceptive2009/contracept2009_wallchart_front.pdf. (дата обращения 01.06.2013).
  21. Strategic Approaches to the Prevention of HIV Infection in Infants; Report of a WHO meeting; Morges Switzerland. 20– 22 March 2002 URL: http: // www.who.int/hiv/pub/mtct/en/StrategicApproachesE.pdf. (дата обращения 01.06.2013).
  22. Wand H., Ramjee G. The effects of injectable hormonal contraceptives on HIV seroconversion and on sexually transmitted infections // AIDS. — 2012. — Vol. 28, N 26, pt. 3. — P. 375-380.
  23. World Health Organization medical eligibility criteria for contraceptive use. — 3rd ed. — Geneva: WHO, 2004.
  24. World Health Organization medical eligibility criteria for contraceptive use, 2008 Update. Geneva: WHO. — 2008. URL: http://www.who.int/reproductive-health/publications/mec/mec-update_ 2008.pdf. (дата обращения 01.06.2013).
  25. World Health Organization. Review of priorities in research on hormonal contraception and IUDs and HIV infection: Report of a technical meeting; Geneva. 13–15 March 2007. — Geneva, 2010.

补充文件

附件文件
动作
1. JATS XML
下载

版权所有 © Samarina A.V., Lisitsina Z.N., Martirosyan M.M., Dementyeva N.Y., Krutitskaya L.I., Rakhmanova A.G., Belyakov N.A., 2013

Creative Commons License
此作品已接受知识共享署名 4.0国际许可协议的许可

Согласие на обработку персональных данных

 

Используя сайт https://journals.rcsi.science, я (далее – «Пользователь» или «Субъект персональных данных») даю согласие на обработку персональных данных на этом сайте (текст Согласия) и на обработку персональных данных с помощью сервиса «Яндекс.Метрика» (текст Согласия).